The Journal of Neuroscience, December 19, 2007, 27(51):14108-14116; doi:10.1523/JNEUROSCI.2618-07.2007
Previous Article | Next Article 
Neurobiology of Disease
GABAA Receptor
2 Subunit Mutations Linked to Human Epileptic Syndromes Differentially Affect Phasic and Tonic Inhibition
Emmanuel Eugène,1,2
Christel Depienne,2,3
Stéphanie Baulac,2,3
Michel Baulac,1,2,4
Jean Marc Fritschy,5
Eric Le Guern,2,3
Richard Miles,1,2 and
Jean Christophe Poncer1,2,6
1Inserm, Unité 739, 75013 Paris, France, 2Université Pierre et Marie Curie-Paris 6, Institut Fédératif de Recherche 70, 75013 Paris, France, 3Inserm, Unité 679, 75013 Paris, France, 4Assistance Publ Hop Paris, Hopital Pitié Salpétrière, Service de Neurologie, 75013 Paris, France, 5Institute for Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland, and 6Inserm, Unité 839, 75005 Paris, France
Correspondence should be addressed to Jean Christophe Poncer, Inserm, Unité 839, Avenir Team "Plasticity in Cortical Networks and Epilepsy," Institut du Fer à Moulin, 17 rue du Fer à Moulin, 75005 Paris, France. Email: poncer{at}fer-a-moulin.inserm.fr
GABA acts on GABAA receptors to evoke both phasic inhibitory synaptic events and persistent, tonic currents. The
2 subunit of the GABAA receptor is involved in both phasic and tonic signaling in the hippocampus. Several mutations of this subunit are linked to human epileptic syndromes with febrile seizures, yet it is not clear how they perturb neuronal activity. Here, we examined the expression and functional impact of recombinant
2 in hippocampal neurons. We show that the K289M mutation has no effect on membrane trafficking and synaptic aggregation of recombinant
2, but accelerates the decay of synaptic currents. In contrast, the R43Q mutation primarily reduces surface expression of recombinant
2. However, it has no dominant effect on synaptic currents but instead reduces tonic GABA currents, at least in part by reducing surface expression of the
5 subunit. Our data suggests that the phenotypic specificity of mutations affecting the GABAA receptor
2 gene may result from different actions specific to distinct modes of GABAergic signaling.
Key words: GABA; GABAA receptor; epilepsy; hippocampus; synaptic transmission; benzodiazepine
Received June 8, 2007;
revised Nov. 2, 2007;
accepted Nov. 2, 2007.
Correspondence should be addressed to Jean Christophe Poncer, Inserm, Unité 839, Avenir Team "Plasticity in Cortical Networks and Epilepsy," Institut du Fer à Moulin, 17 rue du Fer à Moulin, 75005 Paris, France. Email: poncer{at}fer-a-moulin.inserm.fr
This article has been cited by other articles:

|
 |

|
 |
 
M. P. Goldschen-Ohm, D. A. Wagner, S. Petrou, and M. V. Jones
An Epilepsy-Related Region in the GABAA Receptor Mediates Long-Distance Effects on GABA and Benzodiazepine Binding Sites
Mol. Pharmacol.,
January 1, 2010;
77(1):
35 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bradley, R. Luo, T. S. Otis, and D. A. DiGregorio
Submillisecond Optical Reporting of Membrane Potential In Situ Using a Neuronal Tracer Dye
J. Neurosci.,
July 22, 2009;
29(29):
9197 - 9209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, E. Spary, J. Deuchars, and S. A. Deuchars
Tonic GABAergic Inhibition of Sympathetic Preganglionic Neurons: A Novel Substrate for Sympathetic Control
J. Neurosci.,
November 19, 2008;
28(47):
12445 - 12452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bard, C. Boscher, M. Lambert, R.-M. Mege, D. Choquet, and O. Thoumine
A Molecular Clutch between the Actin Flow and N-Cadherin Adhesions Drives Growth Cone Migration
J. Neurosci.,
June 4, 2008;
28(23):
5879 - 5890.
[Abstract]
[Full Text]
[PDF]
|
 |
|